Search Results

Filter
  • 1-10 of  1,308 results for ""Factor Xa Inhibitors""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A Retrospective Review of Four-Factor Prothrombin Complex Concentrate for Factor Xa Inhibitor-Related Bleedings.

  • Authors : Hitchcock ZR; Pharmacy Department at CoxHealth South National Avenue, Springfield, MO, USA.; Smith SD

Subjects: Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/adverse effects ; Thromboembolism*; Humans

  • Source: Journal of pharmacy practice [J Pharm Pract] 2023 Apr; Vol. 36 (2), pp. 221-226. Date of Electronic Publication: 2021 Jul 07.Publisher: Sage Publications Country of Publication: United States NLM ID: 8900945 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Evaluation of the Effectiveness and Safety of Direct Oral Anticoagulants in Elderly Patients With Nonvalvular Atrial Fibrillation Who Are Not Candidates for Warfarin in Real-World Setting.

  • Authors : Lo CT; Ambulatory Care, Central Valley Service Area, Kaiser Permanente, Modesto, CA.; Niu F

Subjects: Drug Costs*; Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*drug therapy ; Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*economics

  • Source: Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2022 Jan 01; Vol. 79 (1), pp. e138-e143.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7902492 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding.

  • Authors : Rech MA; Loyola University Medical Center, Department of Pharmacy, Maywood, Illinois.; Stritch School of Medicine, Loyola University Chicago, Department of Emergency Medicine, Maywood, Illinois.

Subjects: Anticoagulants/Anticoagulants/Anticoagulants/*adverse effects ; Blood Coagulation Factors/Blood Coagulation Factors/Blood Coagulation Factors/*adverse effects ; Factor Xa Inhibitors/Factor Xa Inhibitors/Factor Xa Inhibitors/*adverse effects

  • Source: The western journal of emergency medicine [West J Emerg Med] 2021 Feb 26; Vol. 22 (2), pp. 163-169. Date of Electronic Publication: 2021 Feb 26.Publisher: Department of Emergency Medicine, University of California, Irvine Country of Publication: United States NLM ID: 101476450 Publication Model:

Record details

×
Academic Journal

Emergent reversal of oral factor Xa inhibitors with four-factor prothrombin complex concentrate.

  • Authors : Lipari L; Department of Pharmacy, Research Medical Center, Kansas City, MO, USA. Electronic address: .; Yang S

Subjects: Blood Coagulation Factors/Blood Coagulation Factors/Blood Coagulation Factors/*therapeutic use ; Factor Xa Inhibitors/Factor Xa Inhibitors/Factor Xa Inhibitors/*adverse effects ; Hemorrhage/Hemorrhage/Hemorrhage/*therapy

  • Source: The American journal of emergency medicine [Am J Emerg Med] 2020 Dec; Vol. 38 (12), pp. 2641-2645. Date of Electronic Publication: 2020 Aug 19.Publisher: W B Saunders Country of Publication: United States NLM ID: 8309942 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Management of Anticoagulation Therapy in Patients With Thromboembolism in the Context of Renal Dysfunction: Challenging Cases and Practical Algorithms.

  • Authors : Bahabri A; Department of Pediatrics, Division of Pediatric Hematology-Oncology.; Chan AKC

Subjects: Algorithms*; Acute Kidney Injury/Acute Kidney Injury/Acute Kidney Injury/*complications ; Enoxaparin/Enoxaparin/Enoxaparin/*administration & dosage

  • Source: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2021 Oct 01; Vol. 43 (7), pp. e1040-e1044.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505928 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms.

  • Authors : Huenerbein K; University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, UKRUB, University of Bochum, Hans-Nolte-Straße 1, D-32429, Minden, Germany. .; Sadjadian P

Subjects: Secondary Prevention*; Factor Xa Inhibitors/Factor Xa Inhibitors/Factor Xa Inhibitors/*therapeutic use ; Myeloproliferative Disorders/Myeloproliferative Disorders/Myeloproliferative Disorders/*complications

  • Source: Annals of hematology [Ann Hematol] 2021 Aug; Vol. 100 (8), pp. 2015-2022. Date of Electronic Publication: 2020 Nov 20.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Direct oral anticoagulants and cardiac surgery: A descriptive study of preoperative management and postoperative outcomes.

  • Authors : Fox V; Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen, Germany.; Kleikamp A

Subjects: Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/administration & dosage ; Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/adverse effects ; Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/classification

  • Source: The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2021 May; Vol. 161 (5), pp. 1864-1874.e2. Date of Electronic Publication: 2019 Dec 17.Publisher: Mosby Country of Publication: United States NLM ID: 0376343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-685X

Record details

×
Report

Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy: Insights From the ARISTOTLE Trial.

  • Authors : Al-Khatib SM; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (S.M.A.-K., H.M., D.W., R.D.L., J.H.A., C.B.G.).; Mulder H

Subjects: Anticoagulants/Anticoagulants/Anticoagulants/*therapeutic use ; Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*drug therapy ; Factor Xa Inhibitors/Factor Xa Inhibitors/Factor Xa Inhibitors/*therapeutic use

  • Source: Circulation. Arrhythmia and electrophysiology [Circ Arrhythm Electrophysiol] 2021 Mar; Vol. 14 (3), pp. e009614. Date of Electronic Publication: 2021 Mar 04.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101474365 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin.

  • Authors : Coleman CI; University of Connecticut School of Pharmacy, 69 North Eagleville Road, Unit 3092, Storrs, CT, 06269, USA. .; Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USA. .

Subjects: Anticoagulants/Anticoagulants/Anticoagulants/*therapeutic use ; Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*drug therapy ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*epidemiology

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2021 Feb 26; Vol. 20 (1), pp. 52. Date of Electronic Publication: 2021 Feb 26.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

×
Academic Journal

New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting and Long-Term Outcome: A Population-Based Nationwide Study From the SWEDEHEART Registry.

  • Authors : Taha A; Department of Molecular and Clinical Medicine Institute of Medicine Sahlgrenska AcademyUniversity of Gothenburg Sweden.; Department of Cardiology Region Västra GötalandSahlgrenska University Hospital Gothenburg Sweden.

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/diagnosis ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/epidemiology

  • Source: Journal of the American Heart Association [J Am Heart Assoc] 2021 Jan 05; Vol. 10 (1), pp. e017966. Date of Electronic Publication: 2020 Nov 30.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  1,308 results for ""Factor Xa Inhibitors""